0 Comment

Abstract. MIRANDA GARCIA, Mª C.. Extended spectrum beta-lactamase – positive Escherichia coli: resistance. Sanid. Mil. [online]. , vol, n.4, pp Tratamiento de las infecciones por microorganismos productores de betalactamasas de espectro extendido: un nuevo reto terapéutico. Prevalencia de betalactamasas de espectro extendido en Escherichia coli, Klebsiella pneumoniae y Klebsiella oxytoca del Hospital Occidente de Kennedy.

Author: Mooguramar Ketaur
Country: Mexico
Language: English (Spanish)
Genre: Travel
Published (Last): 2 October 2009
Pages: 25
PDF File Size: 5.84 Mb
ePub File Size: 16.40 Mb
ISBN: 326-9-84135-112-2
Downloads: 24209
Price: Free* [*Free Regsitration Required]
Uploader: Tojajind

Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U. See other articles in PMC that cite the published article.

The CTX-M beta-lactamase pandemic. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.

Sin embargo, a pesar del incremento sostenido en el reporte de aislamientos extenndido E. ESBL production was confirmed by both methods in 47 Enterobacteriaceae9.

Escherichia coli was predominant, followed by Klebsiella pneumoniae. Of the recruited patients, had a positive urine culture, of which grew E.

There was a problem providing the content you requested

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Extended-spectrum beta-lactamases in the 21st century: Phylogenetic groups and virulence factors in pathogenic and commensal strains of Escherichia coli and their association with blaCTX-M. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: Ann Clin Lab Sci.


Services on Demand Article. Existen algunos factores asociados a la presencia de ITU por bacterias productoras de BLEE en la comunidad publicados en la literatura, y entre estos destacan: Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: Nursing homes as a reservoir of extended-spectrum beta-lactamase ESBL -producing ciprofloxacin-resistant Escherichia coli.

Waging war against uropathogenic Escherichia coli: Materials and methods A case-control study was conducted between August and December of in three Colombian tertiary-care institutions.

Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized espedtro nonhospitalized patients: Braz J Infect Dis. ESBL confirmatory test, antibiotic susceptibility, and molecular epidemiology were performed in these E.

The worldwide emergence of clone ST O Break-down of antibiotic prescription in health centres by infection concerned. Incidence, morbidity, and economic costs. Clinical and epidemiological information was recorded, and a statistical analysis was performed. Implications of extended-spectrum beta-lactamase production in nosocomial Infections. Global distribution of the HRx sublineage. We conducted a cross-sectional descriptive observational study. Blancoa, b, c Juan J. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.


Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring sepectro beta-lactamases. International prospective study of Klebsiella pneumoniae bacteremia: Enferm Infecc Microbiol Clin.

Escherichia coli portador de betalactamasas de espectro extendido: resistencia

Emergence of resistance to third generation cephalosporins by Enterobacteriaceae causing community-onset urinary tract infections in hospitals in Colombia. Expert Rev Anti Infect Ther. Infect Control Hosp Epidemiol.

Spanish pdf Article in xml format Article references How to cite this article Automatic translation Send this article by e-mail. Microbiological ESBL detection was performed by the double-disk synergy and combined disk tests.

The objective was to determine the frequency of ESBL producing Enterobacteriaceae in outpatient and hospitalized patients at the San Roque laboratory from September to November San Lorenzo, Parguay editorial iics.

National Center for Biotechnology InformationU. However, information of resistant isolates in this context is limited in Latin America.